Minerva Neurosciences (NERV) Total Debt (2013 - 2018)

Minerva Neurosciences (NERV) has 4 years of Total Debt data on file, last reported at $1.3 million in Q2 2017.

• Quarterly Total Debt fell 78.69% year-over-year to $1.3 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.3 million (down 78.69% YoY) and the FY2016 annual result came in at $3.8 million, down 54.83% from the prior year.
• Total Debt fell to $1.3 million in Q2 2017, from $2.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $9.6 million in Q3 2015 to a low of $1.3 million in Q2 2017.
• A 4-year average of $5.8 million and a median of $6.2 million in 2016 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2015 — Total Debt soared 528.92% — and 2017, when it tumbled 78.69%.
• Tracing NERV's Total Debt over 4 years: stood at $1.4 million in 2014, then soared by 514.91% to $8.5 million in 2015, then sank by 54.83% to $3.8 million in 2016, then plunged by 65.47% to $1.3 million in 2017.
• The last three Total Debt figures came in at $1.3 million (Q2 2017), $2.6 million (Q1 2017), and $3.8 million (Q4 2016), per Business Quant data.